CareRx Corporation

CRRX

CA14173C1059

Drug Retailers

Market Closed - Toronto S.E. Other stock markets 01:52:29 2024-04-26 pm EDT			5-day change	1st Jan Change
2.4 ^CAD	+0.84%		+6.67%	+49.07%

Apr. 01	CareRx Down 3% as Notes Ontario Government's Pause of Planned Fee Changes	MT
Apr. 01	CareRx Brief: Notes Ontario Government's Pause of Planned Fee Changes	MT

Tranche Update on CareRx Corporation's Equity Buyback Plan announced on August 28, 2023.

November 08, 2023 at 07:10 am EST

From August 28, 2023 to September 30, 2023, the company has repurchased 29,392 shares, representing 0.05% for CAD 0.06 million. With this, the company has completed the repurchase of 29,392 shares, representing 0.05% for CAD 0.06 million under the buyback announced on August 28, 2023.

Latest news about CareRx Corporation

CareRx Down 3% as Notes Ontario Government's Pause of Planned Fee Changes	Apr. 01	MT
CareRx Brief: Notes Ontario Government's Pause of Planned Fee Changes	Apr. 01	MT
CareRx Brief: In connection with Prior announced normal course issuer bid to Buy Up To 1 Million of its common shares, it has entered into an automatic share purchase plan	Mar. 27	MT
CareRx Narrows Q4 Loss, Revenue Falls	Mar. 07	MT
Transcript : CareRx Corporation, Q4 2023 Earnings Call, Mar 07, 2024	Mar. 07
CareRx Brief: Revenue for Q4 $91.1 million; Net loss for the quarter was $3.7 million	Mar. 07	MT
CareRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
CareRx Corporation Reports Goodwill and Intangible Assets Impairment Charges for the Fourth Quarter Ended December 31, 2023	Mar. 07	CI
North American Morning Briefing : Powell Still in -2-	Mar. 07	DJ
North American Morning Briefing : Powell Still in the Spotlight; ECB Rate Decision Looms	Mar. 07	DJ
CareRx Corporation Announces Closing of $70 Million Debt Refinancing	Dec. 21	CI
CareRx Completes C$70-Million Debt Refinancing	Dec. 21	MT
CareRx Brief: Says Closed $70 Million Debt Refinancing	Dec. 21	MT
CareRx Announced $70 million Debt Refinancing	Dec. 11	MT
CareRx Brief: Announcing $70 million Debt Refinancing	Dec. 11	MT
CareRx Corporation Announces $70 Million Debt Refinancing	Dec. 11	CI
Transcript : CareRx Corporation, Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
Tranche Update on CareRx Corporation's Equity Buyback Plan announced on August 28, 2023.	Nov. 08	CI
CareRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
North American Morning Briefing : Stock Futures -2-	Nov. 08	DJ
CareRx Says Received Regulatory Approval for Launch of its Normal Course Issuer Bid	23-09-05	MT
CareRx Brief: Says Received Regulatory Approval for Launch of its Normal Course Issuer Bid	23-09-05	MT
CareRx Plans to Buy Back Shares Through a Normal-Course Issuer Bid	23-08-28	MT
CareRx Corporation announces an Equity Buyback for 1,000,000 shares, representing 1.73% of its issued share capital.	23-08-28	CI
CareRx Corporation authorizes a Buyback Plan.	23-08-27	CI

Chart CareRx Corporation

Duration

Period

More charts

Company Profile

CareRx Corporation is a Canada-based provider of pharmacy services to seniors living communities. The Company serves over 94,000 residents in over 1,500 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. It supports its home care partners by providing solutions for the supply of chronic medication. It offers a range of medication solutions. Its technology automates the preparation and verification of multi-dose compliance packaging of medication, providing the safety and adherence for individuals with complex medication regimes. Its network of pharmacy fulfillment centers delivers solutions for the supply of chronic medication and other specialty clinical pharmacy services. The Company provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. It works with home operator partners to promote resident health, staff education and others.

Sector

Drug Retailers

Calendar

2024-05-07 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for CareRx Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.4 CAD

Average target price

3.656 CAD

Spread / Average Target

+52.34%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
CARERX CORPORATION	+49.07%	105M
WALGREENS BOOTS ALLIANCE, INC.	-32.21%	15.27B
JD HEALTH INTERNATIONAL INC.	-31.97%	10.84B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-30.42%	6.06B
YIFENG PHARMACY CHAIN CO., LTD.	+8.14%	6.04B
MATSUKIYOCOCOKARA & CO.	-11.41%	5.86B
NAHDI MEDICAL COMPANY	-0.88%	4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+52.19%	4.29B
CLICKS GROUP LIMITED	-12.31%	3.61B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-14.86%	3.33B

Other Drug Retailers

CareRx Corporation

Equities

CRRX

CA14173C1059

Drug Retailers

Tranche Update on CareRx Corporation's Equity Buyback Plan announced on August 28, 2023.

EPS Revisions